138 related articles for article (PubMed ID: 37544132)
1. The mtDNA fragments within exosomes might be novel diagnostic biomarkers of non-small cell lung cancer.
Lou C; Ma X; Chen Z; Zhao Y; Yao Q; Zhou C; Zhao X; Meng X
Pathol Res Pract; 2023 Sep; 249():154718. PubMed ID: 37544132
[TBL] [Abstract][Full Text] [Related]
2. Serum exosomal hsa_circ_0069313 has a potential to diagnose more aggressive non-small cell lung cancer.
Chen Y; Lou C; Ma X; Zhou C; Zhao X; Li N; Tian H; Meng X
Clin Biochem; 2022 Apr; 102():56-64. PubMed ID: 35077682
[TBL] [Abstract][Full Text] [Related]
3. PLA2G10 incorporated in exosomes could be diagnostic and prognostic biomarker for non-small cell lung cancer.
Chen Y; Ma X; Lou C; Zhou C; Zhao X; Li N; Tian H; Meng X
Clin Chim Acta; 2022 May; 530():55-65. PubMed ID: 35231479
[TBL] [Abstract][Full Text] [Related]
4. Plasma versican and plasma exosomal versican as potential diagnostic markers for non-small cell lung cancer.
Chang W; Zhu J; Yang D; Shang A; Sun Z; Quan W; Li D
Respir Res; 2023 May; 24(1):140. PubMed ID: 37259101
[TBL] [Abstract][Full Text] [Related]
5. Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.
Gao J; Qiu X; Li X; Fan H; Zhang F; Lv T; Song Y
Biochem Biophys Res Commun; 2018 Apr; 498(3):409-415. PubMed ID: 29452091
[TBL] [Abstract][Full Text] [Related]
6. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
Zhang Y; Xu H
J Clin Lab Anal; 2020 Jun; 34(6):e23237. PubMed ID: 32061007
[TBL] [Abstract][Full Text] [Related]
7. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
8. Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4.
Kim DH; Park S; Kim H; Choi YJ; Kim SY; Sung KJ; Sung YH; Choi CM; Yun M; Yi YS; Lee CW; Kim SY; Lee JC; Rho JK
Cancer Lett; 2020 Apr; 475():2-13. PubMed ID: 32004570
[TBL] [Abstract][Full Text] [Related]
9. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel linc01125 isoform in serum exosomes as a promising biomarker for NSCLC diagnosis and survival assessment.
Xian J; Zeng Y; Chen S; Lu L; Liu L; Chen J; Rao B; Zhao Z; Liu J; Xie C; Zhu L; Zhang D; Qiu F; Lu J; Yang L
Carcinogenesis; 2021 Jun; 42(6):831-841. PubMed ID: 33928340
[TBL] [Abstract][Full Text] [Related]
11. Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients.
Janpipatkul K; Trachu N; Watcharenwong P; Panvongsa W; Worakitchanon W; Metheetrairut C; Oranratnachai S; Reungwetwattana T; Chairoungdua A
Cancer Biomark; 2021; 31(3):281-294. PubMed ID: 33896827
[TBL] [Abstract][Full Text] [Related]
12. Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool.
Giallombardo M; Chacártegui Borrás J; Castiglia M; Van Der Steen N; Mertens I; Pauwels P; Peeters M; Rolfo C
J Vis Exp; 2016 May; (111):. PubMed ID: 27285610
[TBL] [Abstract][Full Text] [Related]
13. The Value of Serum Exosomal miR-184 in the Diagnosis of NSCLC.
Li S; Lin Y; Wu Y; Chen H; Huang Z; Lin M; Dong J; Wang Y; Yang Z
J Healthc Eng; 2022; 2022():9713218. PubMed ID: 35444778
[TBL] [Abstract][Full Text] [Related]
14. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
[TBL] [Abstract][Full Text] [Related]
15. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319
[TBL] [Abstract][Full Text] [Related]
16. Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer.
Han P; Zhao J; Gao L
J Clin Lab Anal; 2021 Nov; 35(11):e23979. PubMed ID: 34551140
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
18. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
Zhang R; Xia Y; Wang Z; Zheng J; Chen Y; Li X; Wang Y; Ming H
Biochem Biophys Res Commun; 2017 Aug; 490(2):406-414. PubMed ID: 28623135
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic potential of a circRNA-miRNA network in non-small cell lung cancer.
Ma X; Lou C; Pan J; Zhou C; Zhao X; Li N; Tian H; Meng X
J Mol Med (Berl); 2023 Jun; 101(6):671-684. PubMed ID: 37069371
[TBL] [Abstract][Full Text] [Related]
20. Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancer.
Min L; Zhu T; Lv B; An T; Zhang Q; Shang Y; Yu Z; Zheng L; Wang Q
Int J Clin Oncol; 2022 Jun; 27(6):1013-1024. PubMed ID: 35482171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
